Senior insider sale
Chief Executive Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$562.6K
20.82K shares
What this filing means
KROEGER CHRISTOPHER A. plans to sell 20.82K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $562.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001974158-26-000049
DirectorOfficer· Chief Executive Officer
Since Feb 2026
20.82K
Shares to sell
$562.6K
Approx. market value
46.73K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Unit Grant
N/A
5/2/2024
24.22KRestricted Stock Unit Grant
N/A
11/9/2023
7.66KRestricted Stock Unit Grant
N/A
7/30/2023
14.84KTotal acquired46.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2024 | Restricted Stock Unit Grant N/A | 24.22K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 7.66K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 14.84K | — |
| Total | 46.73K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20.82K
Market value
$562.6K
4/15/2026
Total
Units
20.82K
Value
$562.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/15/2026 | 20.82K | $562.6K | NASDAQ | Planned |
| Total | 20.82K | $562.6K | ||